Cardiol Therapeutics (CRDL) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $1.15, +0.88% vs the prior close of $1.14.
- Volume 629.10K shares, 0.4x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CRDL rises 0.9% to $1.15. Closed at $1.15, +0.88% vs the prior close of $1.14. Day range $1.12–$1.17, opened at $1.16.
CRDL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CRDL rises 0.9% to $1.15
- Closed at $1.15, +0.88% vs the prior close of $1.14. Day range $1.12–$1.17, opened at $1.16.
- Volume was 629.10K shares, 0.4x its 50-day average of 1.58M — lighter than usual.
- Price is -33.8% vs its 50-day average ($1.74) and -11.2% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 18% of that range, 50.9% below the 52-week high.
Oct 14, 2026 — CRDL slides 5.0% to $1.14, a 3-month low
- Closed at $1.14, -5.00% vs the prior close of $1.20. Day range $1.13–$1.20, opened at $1.20.
- Volume was 829.90K shares, 0.5x its 50-day average of 1.59M — lighter than usual.
- Price is -34.6% vs its 50-day average ($1.74) and -11.9% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 18% of that range, 51.3% below the 52-week high.
Oct 13, 2026 — CRDL rises 1.7% to $1.20
- Closed at $1.20, +1.69% vs the prior close of $1.18. Day range $1.18–$1.24, opened at $1.22.
- Volume was 2.03M shares, 1.3x its 50-day average of 1.57M.
- Price is -31.3% vs its 50-day average ($1.75) and -7.2% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 22% of that range, 48.7% below the 52-week high.
Oct 12, 2026 — CRDL slides 4.1% to $1.18, a 1-month low, 3 down days in a row
- Closed at $1.18, -4.07% vs the prior close of $1.23. Day range $1.18–$1.29, opened at $1.27.
- Volume was 1.76M shares, 1.1x its 50-day average of 1.55M.
- Price is -32.5% vs its 50-day average ($1.75) and -8.7% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 21% of that range, 49.6% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — CRDL slides 5.4% to $1.23, a 1-month low
- Closed at $1.23, -5.38% vs the prior close of $1.30. Day range $1.23–$1.32, opened at $1.32.
- Volume was 1.26M shares, 0.8x its 50-day average of 1.55M.
- Price is -29.7% vs its 50-day average ($1.75) and -4.8% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 24% of that range, 47.4% below the 52-week high.
Oct 8, 2026 — CRDL dips 1.5% to $1.30, a 1-month low
- Closed at $1.30, -1.52% vs the prior close of $1.32. Day range $1.26–$1.34, opened at $1.29.
- Volume was 925.30K shares, 0.6x its 50-day average of 1.55M — lighter than usual.
- Price is -25.7% vs its 50-day average ($1.75) and +0.7% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 29% of that range, 44.4% below the 52-week high.
Oct 7, 2026 — CRDL rises 0.8% to $1.32 on 2.5x normal volume
- Closed at $1.32, +0.76% vs the prior close of $1.31. Day range $1.28–$1.38, opened at $1.31.
- Volume was 3.75M shares, 2.5x its 50-day average of 1.49M — unusually heavy trading.
- Price is -24.4% vs its 50-day average ($1.75) and +2.4% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 30% of that range, 43.6% below the 52-week high.
Oct 6, 2026 — CRDL dips 0.8% to $1.31, a 1-month low on 3.3x normal volume
- Closed at $1.31, -0.76% vs the prior close of $1.32. Day range $1.28–$1.37, opened at $1.33.
- Volume was 4.71M shares, 3.3x its 50-day average of 1.41M — unusually heavy trading.
- Price is -24.9% vs its 50-day average ($1.74) and +1.8% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 29% of that range, 44.0% below the 52-week high.
- That makes 10 straight losses.
Oct 5, 2026 — CRDL slides 6.4% to $1.32, a 1-month low on 2.2x normal volume
- Closed at $1.32, -6.38% vs the prior close of $1.41. Day range $1.28–$1.40, opened at $1.40.
- Volume was 2.96M shares, 2.2x its 50-day average of 1.36M — unusually heavy trading.
- Price is -24.2% vs its 50-day average ($1.74) and +2.7% vs its 200-day average ($1.29).
- 52-week range $0.88–$2.34; today's close sits at 30% of that range, 43.6% below the 52-week high.
- That makes 9 straight losses.
Oct 2, 2026 — CRDL slides 9.6% to $1.41, a 1-month low on 2.7x normal volume
- Closed at $1.41, -9.62% vs the prior close of $1.56. Day range $1.40–$1.64, opened at $1.60.
- Volume was 3.59M shares, 2.7x its 50-day average of 1.31M — unusually heavy trading.
- Price is -18.9% vs its 50-day average ($1.74) and +9.8% vs its 200-day average ($1.28).
- 52-week range $0.88–$2.34; today's close sits at 36% of that range, 39.7% below the 52-week high.
- That makes 8 straight losses.
CRDL latest news & SEC filings
Every SEC filing by or about CRDL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 23, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 16, 2026 · Form F-10/A — F-10/A filing
F-10/A filing
Sep 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 15, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 11, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 5, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade CRDL
- How much it moves: over the last 20 sessions the average daily move was 2.90% (largest 9.6%).
- Liquidity: about 1.65M shares (≈$1.90M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.15 vs a range of $0.88–$2.34 (18% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 23, 2026; 6-K Sep 16, 2026; 6-K Sep 15, 2026.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
CRDL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 1.16 | 1.17 | 1.12 | 1.15 | 629.10K |
| Oct 14, 2026 | 1.20 | 1.20 | 1.13 | 1.14 | 829.90K |
| Oct 13, 2026 | 1.22 | 1.24 | 1.18 | 1.20 | 2.03M |
| Oct 12, 2026 | 1.27 | 1.29 | 1.18 | 1.18 | 1.76M |
| Oct 9, 2026 | 1.32 | 1.32 | 1.23 | 1.23 | 1.26M |
| Oct 8, 2026 | 1.29 | 1.34 | 1.26 | 1.30 | 925.30K |
| Oct 7, 2026 | 1.31 | 1.38 | 1.28 | 1.32 | 3.75M |
| Oct 6, 2026 | 1.33 | 1.37 | 1.28 | 1.31 | 4.71M |
| Oct 5, 2026 | 1.40 | 1.40 | 1.28 | 1.32 | 2.96M |
| Oct 2, 2026 | 1.60 | 1.64 | 1.40 | 1.41 | 3.59M |
| Oct 1, 2026 | 1.61 | 1.65 | 1.52 | 1.56 | 1.83M |
| Sep 30, 2026 | 1.70 | 1.71 | 1.64 | 1.66 | 461.30K |
| Sep 29, 2026 | 1.68 | 1.71 | 1.67 | 1.69 | 677.90K |
| Sep 28, 2026 | 1.69 | 1.70 | 1.65 | 1.69 | 763.60K |
| Sep 25, 2026 | 1.75 | 1.75 | 1.67 | 1.71 | 1.01M |
| Sep 24, 2026 | 1.72 | 1.74 | 1.66 | 1.73 | 1.08M |
| Sep 23, 2026 | 1.86 | 1.91 | 1.72 | 1.77 | 2.11M |
| Sep 22, 2026 | 1.86 | 1.96 | 1.86 | 1.89 | 718.40K |
| Sep 21, 2026 | 1.90 | 1.93 | 1.82 | 1.86 | 1.01M |
| Sep 18, 2026 | 1.88 | 1.98 | 1.84 | 1.88 | 973.90K |
About Cardiol Therapeutics
Cardiol Therapeutics (CRDL) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in OAKVILLE, Ontario, Canada. State of incorporation: Ontario, Canada. Fiscal year ends December 31. SEC CIK 1702123.
CRDL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CRDL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
CRDL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Argenx Se (ARGX)Biogen (BIIB)Halozyme Therapeutics (HALO)Revolution Medicines (RVMD)Recursion Pharmaceuticals (RXRX)ImmunityBio (IBRX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CRDL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.